ArticlePharmaceutical research2026
Hydrogel-Mediated Delivery of Drug Nanocarriers in the Oedematous Postoperative Brain.
Article in Pharmaceutical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PURPOSE AND
objectivesHydrogel-nanocarrier systems have emerged as a clinically implementable strategy to reduce glioblastoma recurrence following surgery. Despite demonstrated feasibility, the influence of intrinsic tissue and nanocarrier properties on delivery outcomes remains insufficiently understood. This study aims to quantify their individual effects on delivery performance.
methodsA mathematical model is applied to simulate hydrogel-mediated nanocarrier delivery to the oedematous postoperative brain. Simulations are conducted in a realistic 3-D brain geometry rebuilt from medical imaging data. Nine factors are investigated, including drug release rate, nanocarrier diffusivity, blood drainage rate, partitioning at the cell membrane and within cells, drug loading dose, oedema severity, blood pressure, and tissue permeability.
resultsThe modelling reveals distinct responses of delivery outcomes to each factor. Optimal ranges are identified that maximise drug availability and/or improve distribution volume and uniformity. The results suggest that drug delivery is controlled predominantly by drug release and elimination rather than transport.
conclusionsThese findings enhance understanding of the coupled interactions between drug transport and brain tissue in the post-operative environment and provide a quantitative reference for the optimisation of hydrogel-nanocarrier delivery systems to improve inhibition of glioblastoma recurrence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.